393 related articles for article (PubMed ID: 29233519)
21. Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment.
Frangioudakis G; Diakanastasis B; Liao BQ; Saville JT; Hoffman NJ; Mitchell TW; Schmitz-Peiffer C
Diabetologia; 2013 Dec; 56(12):2697-701. PubMed ID: 23989724
[TBL] [Abstract][Full Text] [Related]
22. Ceramides inhibit phospholipase D-dependent insulin signaling in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2012 Feb; 77(2):180-6. PubMed ID: 22348478
[TBL] [Abstract][Full Text] [Related]
23. Central visfatin potentiates glucose-stimulated insulin secretion and β-cell mass without increasing serum visfatin levels in diabetic rats.
Kim DS; Kang S; Moon NR; Park S
Cytokine; 2014 Feb; 65(2):159-66. PubMed ID: 24332931
[TBL] [Abstract][Full Text] [Related]
24. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Ceramide De Novo Synthesis Affects Adipocytokine Secretion and Improves Systemic and Adipose Tissue Insulin Sensitivity.
Blachnio-Zabielska AU; Hady HR; Markowski AR; Kurianiuk A; Karwowska A; Górski J; Zabielski P
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545025
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
27. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells.
Xiao-Yun X; Zhuo-Xiong C; Min-Xiang L; Xingxuan H; Schuchman EH; Feng L; Han-Song X; An-Hua L
Med Sci Monit; 2009 Sep; 15(9):BR254-61. PubMed ID: 19721393
[TBL] [Abstract][Full Text] [Related]
28. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.
Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA
J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011
[TBL] [Abstract][Full Text] [Related]
29. Palmitate-induced impairments of β-cell function are linked with generation of specific ceramide species via acylation of sphingosine.
Manukyan L; Ubhayasekera SJ; Bergquist J; Sargsyan E; Bergsten P
Endocrinology; 2015 Mar; 156(3):802-12. PubMed ID: 25535826
[TBL] [Abstract][Full Text] [Related]
30. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion.
Arruda AP; Milanski M; Coope A; Torsoni AS; Ropelle E; Carvalho DP; Carvalheira JB; Velloso LA
Endocrinology; 2011 Apr; 152(4):1314-26. PubMed ID: 21266511
[TBL] [Abstract][Full Text] [Related]
31. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells.
Powell DJ; Turban S; Gray A; Hajduch E; Hundal HS
Biochem J; 2004 Sep; 382(Pt 2):619-29. PubMed ID: 15193147
[TBL] [Abstract][Full Text] [Related]
32. Hot topic: Ceramide inhibits insulin sensitivity in primary bovine adipocytes.
Rico JE; Myers WA; Laub DJ; Davis AN; Zeng Q; McFadden JW
J Dairy Sci; 2018 Apr; 101(4):3428-3432. PubMed ID: 29395144
[TBL] [Abstract][Full Text] [Related]
33. Hypothalamic Glucose Hypersensitivity-Induced Insulin Secretion in the Obese Zücker Rat Is Reversed by Central Ghrelin Treatment.
Carneiro L; Fenech C; Liénard F; Grall S; Abed B; Haydar J; Allard C; Desmoulins L; Paccoud R; Brindisi MC; Mouillot T; Brondel L; Fioramonti X; Pénicaud L; Jacquin-Piques A; Leloup C
Antioxid Redox Signal; 2024 May; 40(13-15):837-849. PubMed ID: 36656675
[No Abstract] [Full Text] [Related]
34. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis.
Kelpe CL; Moore PC; Parazzoli SD; Wicksteed B; Rhodes CJ; Poitout V
J Biol Chem; 2003 Aug; 278(32):30015-21. PubMed ID: 12771145
[TBL] [Abstract][Full Text] [Related]
35. Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 β-cells.
Véret J; Coant N; Berdyshev EV; Skobeleva A; Therville N; Bailbé D; Gorshkova I; Natarajan V; Portha B; Le Stunff H
Biochem J; 2011 Aug; 438(1):177-89. PubMed ID: 21592087
[TBL] [Abstract][Full Text] [Related]
36. Ceramides mediate cigarette smoke-induced metabolic disruption in mice.
Thatcher MO; Tippetts TS; Nelson MB; Swensen AC; Winden DR; Hansen ME; Anderson MC; Johnson IE; Porter JP; Reynolds PR; Bikman BT
Am J Physiol Endocrinol Metab; 2014 Nov; 307(10):E919-27. PubMed ID: 25269485
[TBL] [Abstract][Full Text] [Related]
37. CerS6-dependent ceramide synthesis in hypothalamic neurons promotes ER/mitochondrial stress and impairs glucose homeostasis in obese mice.
Hammerschmidt P; Steculorum SM; Bandet CL; Del Río-Martín A; Steuernagel L; Kohlhaas V; Feldmann M; Varela L; Majcher A; Quatorze Correia M; Klar RFU; Bauder CA; Kaya E; Porniece M; Biglari N; Sieben A; Horvath TL; Hornemann T; Brodesser S; Brüning JC
Nat Commun; 2023 Nov; 14(1):7824. PubMed ID: 38016943
[TBL] [Abstract][Full Text] [Related]
38. Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.
Watt MJ; Barnett AC; Bruce CR; Schenk S; Horowitz JF; Hoy AJ
Diabetologia; 2012 Oct; 55(10):2741-2746. PubMed ID: 22854889
[TBL] [Abstract][Full Text] [Related]
39. Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders.
Magnan C; Le Stunff H
Mol Metab; 2021 Nov; 53():101298. PubMed ID: 34273578
[TBL] [Abstract][Full Text] [Related]
40. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.
Muñoz MC; Argentino DP; Dominici FP; Turyn D; Toblli JE
J Hypertens; 2006 Aug; 24(8):1607-17. PubMed ID: 16877964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
